PE30395A1 - Isoquinolina - Google Patents

Isoquinolina

Info

Publication number
PE30395A1
PE30395A1 PE1994254101A PE25410194A PE30395A1 PE 30395 A1 PE30395 A1 PE 30395A1 PE 1994254101 A PE1994254101 A PE 1994254101A PE 25410194 A PE25410194 A PE 25410194A PE 30395 A1 PE30395 A1 PE 30395A1
Authority
PE
Peru
Prior art keywords
isoquinoline
isoenzyme
obstructive
asthma
inhibit
Prior art date
Application number
PE1994254101A
Other languages
English (en)
Inventor
Reto Naef
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PE30395A1 publication Critical patent/PE30395A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I EN FORMA DE UN ESTER FISIOLOGICAMENTE HIDROLIZABLE O UNA SAL, DONDE R ES ETILO o n-PROPILO; EL CUAL PODRIA INHIBIR LA ENZIMA FOSFODIESTERASA, Y SER SELECTIVO PARA LA ISOENZIMA DE TIPO IV. ES UTIL EN EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS OBSTRUCTIVAS O INFLAMATORIAS (ASMA)
PE1994254101A 1993-11-05 1994-11-03 Isoquinolina PE30395A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322828A GB9322828D0 (en) 1993-11-05 1993-11-05 Organic compounds

Publications (1)

Publication Number Publication Date
PE30395A1 true PE30395A1 (es) 1995-10-25

Family

ID=10744697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994254101A PE30395A1 (es) 1993-11-05 1994-11-03 Isoquinolina

Country Status (26)

Country Link
US (1) US5747506A (es)
EP (1) EP0664289A3 (es)
JP (1) JPH07188176A (es)
KR (1) KR950014073A (es)
CN (1) CN1051998C (es)
AT (1) AT404940B (es)
AU (1) AU685852B2 (es)
CA (1) CA2135000A1 (es)
CH (1) CH688478A5 (es)
CZ (1) CZ282329B6 (es)
DE (1) DE4438737A1 (es)
FI (1) FI945191A (es)
FR (1) FR2711989B1 (es)
GB (2) GB9322828D0 (es)
HK (1) HK1005776A1 (es)
HU (1) HU217120B (es)
IL (1) IL111518A (es)
IT (1) IT1273993B (es)
NO (1) NO302293B1 (es)
NZ (1) NZ264851A (es)
PE (1) PE30395A1 (es)
PL (1) PL178210B1 (es)
RU (1) RU2144027C1 (es)
SK (1) SK280298B6 (es)
TW (1) TW353067B (es)
ZA (1) ZA948738B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
US5919794A (en) * 1998-05-11 1999-07-06 Virginia Commonwealth University Methods of using pharmaceutical tetrahydroisoquinolines
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
DE19930614A1 (de) * 1999-07-02 2001-01-04 Mann & Hummel Filter Filtereinsatz
MXPA02001830A (es) 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
EP1265637A2 (en) * 2000-03-14 2002-12-18 The University Of Western Ontario Compositions and methods for affecting osteogenesis
AU2002224835A1 (en) * 2000-11-14 2002-05-27 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Dihydroisoquinolines as novel phosphodiesterase inhibitors
SK5782003A3 (en) 2000-11-14 2003-10-07 Altana Pharma Ag 3,4-Dihydroisoquinoline and isoquinoline compounds, pharmaceutical composition comprising the same and their use
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
US7795385B2 (en) * 2004-12-17 2010-09-14 Bexar Global, Inc. Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
KR101323448B1 (ko) * 2008-10-02 2013-11-27 아사히 가세이 파마 가부시키가이샤 ８위 치환 이소퀴놀린 유도체 및 이의 용도
US8642536B2 (en) 2008-10-17 2014-02-04 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
KR840002104B1 (ko) * 1980-08-08 1984-11-15 부자 앙드레 신규 이소퀴놀린 유도체의 제법
HU183479B (en) * 1981-06-16 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 6,7-diethoxy-1-aracket-4-ethoxy-3-hydroxy-benzyl-bracket closed-3,4-dihydroisoquinolin
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
GB8328052D0 (en) * 1983-10-20 1983-11-23 Beecham Group Plc Compounds
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
NZ264851A (en) 1996-04-26
SK280298B6 (sk) 1999-11-08
RU2144027C1 (ru) 2000-01-10
HK1005776A1 (en) 1999-01-22
CZ282329B6 (cs) 1997-06-11
ITRM940706A0 (it) 1994-11-03
CN1051998C (zh) 2000-05-03
CN1106801A (zh) 1995-08-16
US5747506A (en) 1998-05-05
EP0664289A2 (en) 1995-07-26
JPH07188176A (ja) 1995-07-25
ATA204894A (de) 1998-08-15
PL178210B1 (pl) 2000-03-31
AU7761094A (en) 1995-05-18
GB2283488A (en) 1995-05-10
FI945191A0 (fi) 1994-11-03
SK131994A3 (en) 1995-06-07
FR2711989B1 (fr) 1996-06-14
NO944187L (no) 1995-05-08
CZ269894A3 (en) 1995-07-12
FI945191A (fi) 1995-05-06
FR2711989A1 (fr) 1995-05-12
GB2283488B (en) 1997-12-03
NO944187D0 (no) 1994-11-03
NO302293B1 (no) 1998-02-16
DE4438737A1 (de) 1995-05-11
ITRM940706A1 (it) 1996-05-03
AT404940B (de) 1999-03-25
PL305705A1 (en) 1995-05-15
IT1273993B (it) 1997-07-14
IL111518A (en) 1999-06-20
TW353067B (en) 1999-02-21
GB9421985D0 (en) 1994-12-21
ZA948738B (en) 1996-05-06
KR950014073A (ko) 1995-06-15
HU217120B (hu) 1999-11-29
RU94040170A (ru) 1996-10-10
IL111518A0 (en) 1995-01-24
CH688478A5 (de) 1997-10-15
HUT71350A (en) 1995-11-28
HU9403184D0 (en) 1994-12-28
EP0664289A3 (en) 1995-09-13
AU685852B2 (en) 1998-01-29
CA2135000A1 (en) 1995-05-06
GB9322828D0 (en) 1993-12-22

Similar Documents

Publication Publication Date Title
PE30395A1 (es) Isoquinolina
TR200102399T2 (tr) Tiyoamid türevleri
BR0107964A (pt) Derivados de nicotinamida benzofundida com heterociclica úteis como inibidores seletivos de isozimas pde4
PE20040689A1 (es) Nuevos derivados de piridazin-3(2h)-ona
HUP9902103A2 (hu) Triarilvegyületek
HK1059044A1 (en) Treatment of statin side effects
HRP20050663A2 (en) Malonamide derivatives as gamma-secretase inhibitors
NO20054476D0 (no) Forbindelser for behandling av smerte
ES2009136A6 (es) Un compuesto
PE20050822A1 (es) Derivados de florfenicol con mejor solubilidad en agua
MA27436A1 (fr) Derives de pyridine inhibiteurs de la cox-2
TNSN08177A1 (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
AU2003293746A1 (en) Crystalline cefdinir salts
AR024380A1 (es) Tienopirimidinas
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
WO2003059875A3 (en) DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
AP2004003094A0 (en) Metabolities of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
EE200200337A (et) Uued ühendid ning nende kasutamine
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
EA200300614A1 (ru) Кристаллические соли металл-глюкозамин сульфата и способы их приготовления
AU560429B2 (en) Spiro-imidazolidines as aldose reductase inhibitors
ES2118842T3 (es) Derivados del acido aminobenzoico.
DK1178960T3 (da) Vitamin D analoger og deres farmaceutiske anvendelse
PE20000262A1 (es) Composiciones para la prevencion y tratamiento del resfriado y sintomas similares a la gripe asociados con infecciones del sistema respiratorio y su metodo de uso
EP1325918A4 (en) CARDIOUS CELL APOPTOSIS INHIBITORS AND TREATMENT / PREVENTION OF HEART DISEASES

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed